Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Medtronic
Boehringer Ingelheim
Dow
Harvard Business School

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC (D.N.J. 2018)

See Plans and Pricing

« Back to Dashboard

KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-11-09
Court District Court, D. New Jersey Date Terminated 2019-06-14
Cause 35:271 Patent Infringement Assigned To Freda L. Wolfson
Jury Demand Plaintiff Referred To Tonianne J. Bongiovanni
Parties ALLERGAN SALES, LLC; KYTHERA BIOPHARMACEUTICALS, INC.; LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR UCLA-MEDICAL CENTER; PHV DEANNA REICHEL; SLAYBACK PHARMA LLC; THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Patents 7,622,130; 7,754,230; 8,101,593; 8,242,294; 8,298,556; 8,367,649; 8,461,140; 8,546,367; 8,653,058; 8,846,066; 8,883,770; 9,522,155; 9,636,349; 9,949,986
Attorneys AMIT SINGHAI; ANDREW J. MILLER; ELEONORE OFOSU-ANTWI; JAMES P. BARABAS; LIZA M. WALSH
Firms Budd Larner, P.C.; Budd Larner, PC
Link to Docket External link to docket
Small Molecule Drugs cited in KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 identifies the following patents as covering Kybella®: U.S. Patent Nos. 7,622,130; 7,754,230; 8,101,593;…four other patents listed in the Orange Book related to Kybella®: U.S. Patent Nos. 7,622,130; 7,754,230… III certification with regard to U.S. Patent Nos. 7,622,130; 7,754,230; 8,298,556 and 8,846,066. …27 PageID: 2 Patent Nos. 8,101,593 (the “’593 patent”); 8,367,649 (the “’649 patent”); and 8,653,058…1. This is an action for patent infringement arising under the patent laws of the United States, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Mallinckrodt
Moodys
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.